{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:24:43Z","timestamp":1774463083080,"version":"3.50.1"},"reference-count":260,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jcyt.2023.04.012","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T08:54:27Z","timestamp":1685350467000},"page":"1125-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Stem cells therapy for diabetes: from past to future"],"prefix":"10.1016","volume":"25","author":[{"given":"Yumin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-951X","authenticated-orcid":false,"given":"Zhongdang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.04.012_bib0001","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0002","doi-asserted-by":"crossref","first-page":"R236","DOI":"10.1016\/S0960-9822(02)00777-7","article-title":"The insulin signalling pathway","volume":"12","author":"Lizcano","year":"2002","journal-title":"Current Biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0003","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mpmed.2018.10.002","article-title":"What is diabetes?","volume":"47","author":"Egan","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0005","article-title":"Therapeutic potential of Wharton's jelly mesenchymal stem cells for diabetes: achievements and challenges","volume":"8","author":"Mohamed","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0006","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0007","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0008","first-page":"110","article-title":"Diagnosis and assessment of hypoglycemia in patients with diabetes mellitus","volume":"69","author":"Scheen","year":"2014","journal-title":"Revue medicale de Liege"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0009","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.stemcr.2015.02.011","article-title":"Treating diet-induced diabetes and obesity with human embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs","volume":"4","author":"Jennifer","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ecl.2013.08.001","article-title":"Diabetic retinopathy: current concepts and emerging therapy","volume":"42","author":"Rosberger","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ackd.2017.11.003","article-title":"Glycemic control as primary prevention for diabetic kidney disease","volume":"25","author":"MacIsaac","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0012","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1464-5491.2003.00996.x","article-title":"A review of basal insulins","volume":"20","author":"Barnett","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0013","first-page":"1303","article-title":"Notes on diabetes treated with extract and by grafts of sheep's pancreas","volume":"2","author":"Williams","year":"1894","journal-title":"The British Medical Journal"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0014","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1399-0012.2005.00378.x","article-title":"Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004","volume":"19","author":"Gruessner","year":"2005","journal-title":"Clinical transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0015","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.transproceed.2022.03.059","article-title":"The 2022 International Pancreas Transplant Registry Report\u2014a review","volume":"54","author":"Gruessner","year":"2022","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0016","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1083\/jcb.42.3.695","article-title":"Beta granule formation in isolated islets of Langerhans: a study by electron microscopic radioautography","volume":"42","author":"Howell","year":"1969","journal-title":"Journal of Cell Biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0017","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrendo.2013.138","article-title":"The current state of pancreas transplantation","volume":"9","author":"Gruessner","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0018","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/ajt.12872","article-title":"Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010","volume":"14","author":"Balamurugan","year":"2014","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0019","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0020","first-page":"2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes (New York, NY)"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0021","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1073\/pnas.76.1.106","article-title":"Expression in Escherichia coli of chemically synthesized genes for human insulin","volume":"76","author":"Goeddel","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5500\/wjt.v5.i4.243","article-title":"Use of genetically-engineered pig donors in islet transplantation","volume":"5","author":"Rita","year":"2015","journal-title":"World Journal of Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0023","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/pr.2011.57","article-title":"Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases","volume":"71","author":"Daikeler","year":"2012","journal-title":"Pediatric research"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0024","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature03728","article-title":"Treatment of severe autoimmune disease by stem-cell transplantation","volume":"435","author":"Sykes","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0025","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0026","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"297","author":"Voltarelli","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0027","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db11-1711","article-title":"Maturation of human embryonic stem cell\u2013derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice","volume":"61","author":"Rezania","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0028","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/1753-0407.12400","article-title":"Efficient generation of functional pancreatic beta-cells from human induced pluripotent stem cells","volume":"9","author":"Yabe","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0029","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0030","article-title":"Knowledge gaps in rodent pancreas biology: taking human pluripotent stem cell-derived pancreatic beta cells into our own hands","volume":"6","author":"Munirah Mohamad","year":"2016","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0031","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0032","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.15252\/embj.201591058","article-title":"Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro","volume":"34","author":"Russ","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.12996","article-title":"An arduous journey from human pluripotent stem cells to functional pancreatic \u03b2 cells","volume":"20","author":"Loo","year":"2018","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0034","doi-asserted-by":"crossref","first-page":"14066","DOI":"10.1074\/jbc.M117.784280","article-title":"Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic \u03b2 cells","volume":"292","author":"Manzar","year":"2017","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0035","first-page":"3490","article-title":"Real-time observation of pancreatic beta cell differentiation from human induced pluripotent stem cells","volume":"11","author":"Wang","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09404-6","article-title":"YAP inhibition enhances the differentiation of functional stem cell-derived insulin-producing \u03b2 cells","volume":"10","author":"Rosado-Olivieri","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-1168-5","article-title":"Charting cellular identity during human in vitro \u03b2-cell differentiation","volume":"569","author":"Veres","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0038","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0039","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic Stem Cell Lines Derived from Human Blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203126","article-title":"Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents","volume":"13","author":"Southard","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0041","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stemcr.2019.11.004","article-title":"Conformal coating of stem cell-derived islets for beta cell replacement in type 1 diabetes","volume":"14","author":"Stock","year":"2020","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0042","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s12015-020-10018-5","article-title":"In vivo differentiation of stem cell-derived human pancreatic progenitors to treat type 1 diabetes","volume":"16","author":"Maloy","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0043","first-page":"1","volume":"1","author":"Lewis","year":"2018","journal-title":"The Pancreas"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0044","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-cellbio-101512-122405","article-title":"Pancreas organogenesis: from lineage determination to morphogenesis","volume":"29","author":"Shih","year":"2013","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/dvdy.22584","article-title":"Pancreas organogenesis: from bud to plexus to gland","volume":"240","author":"Pan","year":"2011","journal-title":"Developmental Dynamics"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0046","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41587-020-0430-6","article-title":"Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells","volume":"38","author":"Hogrebe","year":"2020","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0047","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","article-title":"Acquisition of dynamic function in human stem cell-derived \u03b2 cells","volume":"12","author":"Velazco-Cruz","year":"2019","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0048","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt1393","article-title":"Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo","volume":"26","author":"Kroon","year":"2008","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0049","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41556-018-0271-4","article-title":"Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells","volume":"21","author":"Nair","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","volume":"586","author":"Yoshihara","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0051","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm.4030","article-title":"Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice","volume":"22","author":"Vegas","year":"2016","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0052","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0053","doi-asserted-by":"crossref","first-page":"35145","DOI":"10.1038\/srep35145","article-title":"Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0054","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cell.2018.12.003","article-title":"A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets","volume":"176","author":"Sharon","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-physiol-030212-183754","article-title":"Regulation of insulin secretion in human pancreatic islets","volume":"75","author":"Rorsman","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0056","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cmet.2016.06.020","article-title":"Beta cell hubs dictate pancreatic islet responses to glucose","volume":"24","author":"Johnston","year":"2016","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0057","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tem.2014.02.005","article-title":"Cellular communication and heterogeneity in pancreatic islet insulin secretion dynamics","volume":"25","author":"Benninger","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0058","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db13-0617","article-title":"The beta-Cell\/EC axis: how do islet cells talk to each other?","volume":"63","author":"Peiris","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0059","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tem.2010.06.003","article-title":"The insulin secretory granule as a signaling hub","volume":"21","author":"Suckale","year":"2010","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1089\/scd.2016.0115","article-title":"Development of islet organoids from h9 human embryonic stem cells in biomimetic 3D scaffolds","volume":"26","author":"Wang","year":"2017","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0061","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1074\/jbc.C112.428979","article-title":"Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young","volume":"288","author":"Teo","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0062","doi-asserted-by":"crossref","first-page":"15768","DOI":"10.1073\/pnas.0906894106","article-title":"Generation of pluripotent stem cells from patients with type 1 diabetes","volume":"106","author":"Maehr","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0063","first-page":"1","article-title":"Generation of stem cell-derived \u03b2-cells from patients with type 1 diabetes","volume":"7","author":"Jeffrey","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0064","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/jdi.12727","article-title":"Insulin-producing cells derived from \u2018induced pluripotent stem cells\u2019 of patients with fulminant type 1 diabetes: vulnerability to cytokine insults and increased expression of apoptosis-related genes","volume":"9","author":"Hosokawa","year":"2018","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0066","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5966\/sctm.2011-0044","article-title":"Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes","volume":"1","author":"Kudva","year":"2012","journal-title":"Stem cells translational medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0067","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3858\/emm.2012.44.3.015","article-title":"Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery","volume":"44","author":"Jang","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0068","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2016.02.001","article-title":"Life and death of beta cells in type 1 diabetes: a comprehensive review","volume":"71","author":"Wilcox","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0069","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/73128","article-title":"Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells","volume":"6","author":"Ramiya","year":"2000","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7314\/APJCP.2015.16.2.437","article-title":"Establishment of a pancreatic cancer stem cell model using the SW1990 human pancreatic cancer cell line in nude mice","volume":"16","author":"Pan","year":"2015","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0071","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BST0360353","article-title":"Transdifferentiation of pancreatic ductal cells to endocrine \u03b2-cells","volume":"36","author":"Bonner-Weir","year":"2008","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0072","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1073\/pnas.97.14.7999","article-title":"In vitro cultivation of human islets from expanded ductal tissue","volume":"97","author":"Bonner-Weir","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0073","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/labinvest.3700377","article-title":"Expansion of mesenchymal stem cells from human pancreatic ductal epithelium","volume":"86","author":"Seeberger","year":"2006","journal-title":"Laboratory investigation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0074","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI116708","article-title":"Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells","volume":"92","author":"Wang","year":"1993","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.stem.2014.06.019","article-title":"Loss of Fbw7 reprograms adult pancreatic ductal cells into \u03b1, \u03b4, and \u03b2 cells","volume":"15","author":"Sancho","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2009.05.035","article-title":"The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells","volume":"138","author":"Collombat","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0077","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.2337\/db15-0688","article-title":"BMP-7 induces adult human pancreatic exocrine-to-endocrine conversion","volume":"64","author":"Klein","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0078","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.celrep.2018.02.006","article-title":"P2RY1\/ALK3-expressing cells within the adult human exocrine pancreas are BMP-7 expandable and exhibit progenitor-like characteristics","volume":"22","author":"Qadir","year":"2018","journal-title":"Cell Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0079","doi-asserted-by":"crossref","first-page":"10876","DOI":"10.1073\/pnas.1918314117","article-title":"Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche","volume":"117","author":"Qadir","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0080","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0081","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","article-title":"Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo","volume":"17","author":"Friedenstein","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0082","first-page":"267","article-title":"Fibroblast precursors in normal and irradiated mouse hematopoietic organs","volume":"4","author":"Friedenstein","year":"1976","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0083","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0084","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0086","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cyto.a.23242","article-title":"Isolation, cultivation, and characterization of human mesenchymal stem cells","volume":"93","author":"Mushahary","year":"2018","journal-title":"Cytometry A"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0087","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.stemcr.2016.05.011","article-title":"No identical \"mesenchymal stem cells\" at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels","volume":"6","author":"Sacchetti","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0088","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0089","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2008.02891.x","article-title":"The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro","volume":"126","author":"Meng","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0090","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Experimental hematology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0091","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","article-title":"Immunogenicity of allogeneic mesenchymal stem cells","volume":"16","author":"Schu","year":"2012","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0092","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","article-title":"Biological functions of mesenchymal stem cells and clinical implications","volume":"76","author":"Naji","year":"2019","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0093","first-page":"711","article-title":"Immunomodulatory effect of human umbilical cord blood-derived mesenchymal stem cells on activated T-lymphocyte","volume":"20","author":"Lotfinejad","year":"2021","journal-title":"Iranian Journal of Allergy, Asthma & Immunology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0094","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","article-title":"Mechanisms involved in the therapeutic properties of mesenchymal stem cells","volume":"20","author":"Meirelles Lda","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0095","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/jcb.23250","article-title":"Therapeutic factors secreted by mesenchymal stromal cells and tissue repair","volume":"112","author":"Lee","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0096","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.placenta.2017.04.003","article-title":"Immunomodulatory properties of human placental mesenchymal stem\/stromal cells","volume":"59","author":"Abumaree","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0097","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0098","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2016.00480","article-title":"Immune regulation by pericytes: modulating innate and adaptive immunity","volume":"7","author":"Navarro","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0099","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0100","first-page":"1","article-title":"Mesenchymal stem\/stromal cells as a delivery platform in cell and gene therapies","volume":"13","author":"D'Souza","year":"2015","journal-title":"BMC Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.numecd.2017.02.004","article-title":"Stem cells to restore insulin production and cure diabetes","volume":"27","author":"Sordi","year":"2017","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0102","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V108.11.2558.2558","article-title":"Human pancreatic mesenchymal stem cells produce blood in the non-injury fetal sheep model","volume":"108","author":"Ersek","year":"2006","journal-title":"blood"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0103","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s12015-020-10036-3","article-title":"From mesenchymal stromal\/stem cells to insulin-producing cells: progress and challenges","volume":"16","author":"Ghoneim","year":"2020","journal-title":"Stem Cell Reviews and Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0104","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/bdrc.20156","article-title":"Pancreas cell fate","volume":"87","author":"Guney","year":"2009","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.diff.2009.01.001","article-title":"Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro","volume":"77","author":"Xie","year":"2009","journal-title":"Differentiation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0106","doi-asserted-by":"crossref","DOI":"10.2217\/rme.15.49","article-title":"A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy","volume":"10","author":"El-Demerdash","year":"2015","journal-title":"Regenerative Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0107","first-page":"1","article-title":"Mesenchymal stem cell therapy in type 2 diabetes mellitus","volume":"9","author":"Li","year":"2017","journal-title":"Diabetology & Metabolic Syndrome"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0108","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1517\/14712598.2011.546338","article-title":"Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine","volume":"11","author":"Lau","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0109","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/RLU.0000000000000850","article-title":"Biodistribution of 18F-FDG-labeled autologous bone marrow-derived stem cells in patients with type 2 Diabetes mellitus: exploring targeted and intravenous routes of delivery","volume":"40","author":"Sood","year":"2015","journal-title":"Clinical Nuclear Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0110","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2013.147","article-title":"Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model","volume":"21","author":"Wu","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0111","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nbt841","article-title":"Bone marrow-derived stem cells initiate pancreatic regeneration","volume":"21","author":"Hess","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0112","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1634\/stemcells.2007-0267","article-title":"Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes","volume":"26","author":"Urban","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0113","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/scd.2010.0583","article-title":"Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization","volume":"21","author":"Bell","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0114","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MOT.0000000000000359","article-title":"Mesenchymal stem cells to promote islet transplant survival","volume":"21","author":"English","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0115","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00125-005-1949-2","article-title":"Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?","volume":"48","author":"Meier","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0116","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved beta-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0117","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbmt.2013.04.011","article-title":"Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes","volume":"19","author":"Haller","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0118","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200226","article-title":"Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells","volume":"2013","author":"Dave","year":"2013","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0119","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","article-title":"Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus","volume":"60","author":"Hu","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-95755-4","article-title":"Osteogenic differentiation of human mesenchymal stromal cells and fibroblasts differs depending on tissue origin and replicative senescence","volume":"11","author":"Grotheer","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0121","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/dc15-0171","article-title":"Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion","volume":"39","author":"Cai","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2008.10.004","article-title":"Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia","volume":"32","author":"Boumaza","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186637","article-title":"Intrapancreatic injection of human bone marrow-derived mesenchymal stem\/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice","volume":"12","author":"Murai","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0124","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00125-013-3109-4","article-title":"Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model","volume":"57","author":"Borg","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0125","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1021\/acsnano.7b07643","article-title":"Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving \u03b2-cell destruction","volume":"12","author":"Sun","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0126","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2337\/db11-1141","article-title":"Infusion of mesenchymal stem cells ameliorates hyperglycemia in Type 2 diabetic rats: identification of a novel role in improving insulin sensitivity","volume":"61","author":"Si","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0127","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4252\/wjsc.v11.i1.13","article-title":"Applications of stem cells and bioprinting for potential treatment of diabetes","volume":"11","author":"Kumar","year":"2019","journal-title":"World Journal of Stem Cells"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biocel.2013.11.006","article-title":"Making surrogate \u03b2-cells from mesenchymal stromal cells: perspectives and future endeavors","volume":"46","author":"Bhonde","year":"2014","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.01.001","article-title":"Genome editing in hPSCs reveals GATA6 haploinsufficiency and a genetic interaction with GATA4 in human pancreatic development","volume":"20","author":"Shi","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.molcel.2021.12.002","article-title":"The CRISPR-Cas toolbox and gene editing technologies","volume":"82","author":"Liu","year":"2022","journal-title":"Molecular Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0131","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0132","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nature biotechnology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0133","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0134","doi-asserted-by":"crossref","first-page":"19648","DOI":"10.1038\/srep19648","article-title":"Conversion of embryonic stem cells into extraembryonic lineages by CRISPR-mediated activators","volume":"6","author":"Wei","year":"2016","journal-title":"Scientific reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.stem.2016.07.001","article-title":"Targeted epigenetic remodeling of endogenous loci by CRISPR\/Cas9-based transcriptional activators directly converts fibroblasts to neuronal cells","volume":"19","author":"Black","year":"2016","journal-title":"Cell stem cell"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0136","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/gt.2016.28","article-title":"CRISPR-on system for the activation of the endogenous human INS gene","volume":"23","author":"Gim\u00e9nez","year":"2016","journal-title":"Gene therapy"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0137","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv Biomed Res"},{"issue":"2","key":"10.1016\/j.jcyt.2023.04.012_bib0138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0139","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jgm.2900","article-title":"Promoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells","volume":"18","author":"Gautam","year":"2016","journal-title":"J Gene Med"},{"issue":"4","key":"10.1016\/j.jcyt.2023.04.012_bib0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/1566523215666150630121557","article-title":"A simple high efficiency intra-islet transduction protocol using lentiviral vectors","volume":"15","author":"Jimenez-Moreno Cm Fau - Herrera-Gomez","year":"2015","journal-title":"Curr Gene Ther"},{"issue":"4","key":"10.1016\/j.jcyt.2023.04.012_bib0141","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2010.04.002","article-title":"Immunotherapy of type 1 diabetes: where are we and where should we be going?","volume":"32","author":"Luo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0142","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/genes4030499","article-title":"Genes involved in type 1 diabetes: an update","volume":"4","author":"Hakon","year":"2013","journal-title":"Genes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4615-3448-8_12","article-title":"Expression of insulin-like growth factors (IGFs) and their binding proteins (IGF BPs) during pancreatic development in rat, and modulation of IGF actions on rat islet DNA synthesis by IGF BPs","volume":"321","author":"Hill","year":"1992","journal-title":"Advances in experimental medicine and biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0144","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cellimm.2007.09.010","article-title":"Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology","volume":"252","author":"O'Connor","year":"2008","journal-title":"Cellular immunolog"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pr.109.002469","article-title":"Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?","volume":"62","author":"J","year":"2010","journal-title":"Pharmacological reviews"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0146","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.molmet.2017.05.007","article-title":"AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice","volume":"6","author":"Mallol","year":"2017","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0147","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1189\/jlb.3A0815-371RRR","article-title":"Reg3g overexpression promotes beta cell regeneration and induces immune tolerance in nonobese-diabetic mouse model","volume":"99","author":"Xia","year":"2016","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0148","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.2337\/db15-0066","article-title":"Antiaging gene klotho attenuates pancreatic beta-cell apoptosis in type 1 diabetes","volume":"64","author":"Yi","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0149","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/14712598.4.4.507","article-title":"Hepatocyte growth factor gene therapy for islet transplantation","volume":"4","author":"Rao","year":"2004","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jgm.2692","article-title":"Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy","volume":"15","author":"Ren","year":"2013","journal-title":"J Gene Med"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0151","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112474","article-title":"Modification of a constitutive to glucose-responsive liver-specific promoter resulted in increased efficacy of adeno-associated virus serotype 8-insulin gene therapy of diabetic mice","volume":"9","author":"Sia","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0152","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nature medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0153","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0154","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrendo.2017.80","article-title":"Regulation of hepatic glucose metabolism in health and disease","volume":"13","author":"Petersen","year":"2017","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0155","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1194\/jlr.R094060","article-title":"Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication","volume":"60","author":"Funcke","year":"2019","journal-title":"Journal of lipid research"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0156","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mam.2019.07.001","article-title":"The role of brown and beige adipose tissue in glycaemic control","volume":"68","author":"Klepac","year":"2019","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0157","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.molmet.2017.03.016","article-title":"Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders","volume":"6","author":"Chen","year":"2017","journal-title":"Molecular metabolism"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0158","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI62308","article-title":"Brown adipose tissue regulates glucose homeostasis and insulin sensitivity","volume":"123","author":"Stanford","year":"2013","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0159","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mam.2019.06.004","article-title":"The beneficial effects of brown adipose tissue transplantation","volume":"68","author":"White","year":"2019","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0160","doi-asserted-by":"crossref","first-page":"17291","DOI":"10.1074\/jbc.RA118.004554","article-title":"CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure","volume":"293","author":"Shen","year":"2018","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0161","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1038\/s41467-021-27190-y","article-title":"CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease","volume":"12","author":"Tsagkaraki","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0162","doi-asserted-by":"crossref","first-page":"34","DOI":"10.21037\/sci.2019.08.11","article-title":"A revealing review of mesenchymal stem cells therapy, clinical perspectives and modification strategies","volume":"6","author":"Saeedi","year":"2019","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0163","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.3390\/ijms20153827","article-title":"Current strategies to enhance adipose stem cell function: an update","volume":"20","author":"Seo","year":"2019","journal-title":"International journal of molecular sciences"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0164","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2337\/db15-1418","article-title":"Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection","volume":"65","author":"Coleman","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3727\/096368914X681919","article-title":"Engineered hair follicle mesenchymal stem cells overexpressing controlled-release insulin reverse hyperglycemia in mice with type l diabetes","volume":"24","author":"Wu","year":"2015","journal-title":"Cell Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0166","article-title":"Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression","volume":"8","author":"Wang","year":"2022","journal-title":"Science Advances"},{"issue":"Suppl 22","key":"10.1016\/j.jcyt.2023.04.012_bib0167","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/pedi.12388","article-title":"Insulitis in the pathogenesis of type 1 diabetes","volume":"17","author":"Pugliese","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0168","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3727\/096368914X678445","article-title":"ADSC therapy in neurodegenerative disorders","volume":"23","author":"Chan","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0169","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1590\/S0365-05962010000500008","article-title":"Human adipose-derived stem cells: current challenges and clinical perspectives","volume":"85","author":"Yarak","year":"2010","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0170","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00266-013-0156-7","article-title":"Safety of adipose-derived stem cells and collagenase in fat tissue preparation","volume":"37","author":"Chang","year":"2013","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0171","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/PRS.0b013e31824ecae6","article-title":"Human adipose stem cells: current clinical applications","volume":"129","author":"Gir","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0172","first-page":"1","article-title":"Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints","volume":"14","author":"Jaewoo","year":"2013","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0173","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1479-5876-9-181","article-title":"Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells","volume":"9","author":"Ra","year":"2011","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0174","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/scd.2010.0466","article-title":"Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans","volume":"20","author":"Ra","year":"2011","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0175","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1089\/scd.2016.0163","article-title":"Adipose-derived stem cells enhance cancer stem cell property and tumor formation capacity in lewis lung carcinoma cells through an interleukin-6 paracrine circuit","volume":"25","author":"Lu","year":"2016","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0176","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1387\/ijdb.092953hk","article-title":"Pdx1-transfected adipose tissue-derived stem cells differentiate into insulin-producing cells in vivo and reduce hyperglycemia in diabetic mice","volume":"54","author":"Kajiyama","year":"2010","journal-title":"The International journal of developmental biology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0177","first-page":"13","article-title":"TGF-\u03921 transduced mesenchymal stem cells have profound modulatory effects on DCs and T cells","volume":"14","author":"Saeed","year":"2017","journal-title":"Iranian Journal of Immunology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0178","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.intimp.2017.01.019","article-title":"TGF-beta engineered mesenchymal stem cells (TGF-beta\/MSCs) for treatment of type 1 diabetes (T1D) mice model","volume":"44","author":"Daneshmandi","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.jcyt.2023.04.012_bib0179","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1089\/ars.2012.4963","article-title":"Roles of reactive oxygen species in the fate of stem cells","volume":"20","author":"Chaudhari","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/stem.2429","article-title":"Obesity and type 2 diabetes alters the immune properties of human adipose derived stem cells","volume":"34","author":"Serena","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0181","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13287-019-1393-8","article-title":"Antioxidant-upregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity","volume":"10","author":"Domingues","year":"2019","journal-title":"Stem cell research & therapy"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0182","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178011","article-title":"Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: potential application in the treatment of diabetic neuropathy","volume":"12","author":"Oses","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0183","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00125-015-3638-0","article-title":"Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes","volume":"58","author":"Trahair","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0184","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1055\/s-2004-826175","article-title":"Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes","volume":"36","author":"Nauck","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0185","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4961865","article-title":"GLP-1 gene-modified human umbilical cord mesenchymal stem cell line improves blood glucose level in type 2 diabetic mice","author":"Chang","year":"2019","journal-title":"Stem Cells International"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0186","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s00125-007-0724-y","article-title":"Betacellulin inhibits amylase and glucagon production and promotes beta cell differentiation in mouse embryonic pancreas","volume":"50","author":"Thowfeequ","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0187","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.2337\/diabetes.54.12.3560","article-title":"A functional variant in the human betacellulin gene promoter is associated with type 2 diabetes","volume":"54","author":"Nakano","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0188","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/scd.2009.0490","article-title":"Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats","volume":"20","author":"Paz","year":"2010","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0189","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1135-y","article-title":"Adipocyte-derived stem cell-based gene therapy upon adipogenic differentiation on microcarriers attenuates type 1 diabetes in mice","volume":"10","author":"Fang","year":"2019","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0190","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41587-022-01418-8","article-title":"High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails","volume":"41","author":"Shy","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0191","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","article-title":"Designing and executing prime editing experiments in mammalian cells","volume":"17","author":"Doman","year":"2022","journal-title":"Nature Protocols"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0192","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2036.2010.04424.x","article-title":"Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology","volume":"32","author":"Touchefeu","year":"2010","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0193","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1600-6143.2006.01280.x","article-title":"Clinical operational tolerance after kidney transplantation","volume":"6","author":"Roussey-Kesler","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0194","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5500\/wjt.v3.i4.113","article-title":"Essential concept of transplant immunology for clinical practice","volume":"3","author":"Damodar","year":"2013","journal-title":"World Journal of Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0195","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/08923973.2021.1966033","article-title":"Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs","volume":"43","author":"Parlakpinar","year":"2021","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0196","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/08923973.2012.658921","article-title":"Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice","volume":"34","author":"Castelli","year":"2012","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0197","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/B978-0-444-59575-1.00001-6","article-title":"Transplantation in the future","volume":"200","author":"Gage","year":"2012","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0198","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: a non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0199","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0200","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/ajt.14547","article-title":"Immunoisolation of murine islet allografts in vascularized sites through conformal coating with polyethylene glycol","volume":"18","author":"Manzoli","year":"2018","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0201","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6298","article-title":"Transplanting organs from pigs to humans","volume":"4","author":"Sykes","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tibtech.2003.11.004","article-title":"History, challenges and perspectives of cell microencapsulation","volume":"22","author":"Orive","year":"2004","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0203","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1163\/156856202760197410","article-title":"Improving cell encapsulation through size control","volume":"13","author":"Canaple","year":"2002","journal-title":"Journal of Biomaterials Science \u2013 Polymer Edition"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0167-7799(99)01356-6","article-title":"Rationalizing the design of polymeric biomaterials","volume":"17","author":"Angelova","year":"1999","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0205","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1021\/acs.chemrev.7b00094","article-title":"Functional and biomimetic materials for engineering of the three-dimensional cell microenvironment","volume":"117","author":"Huang","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0206","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2014.0817","article-title":"Natural polymers for the microencapsulation of cells","volume":"11","author":"Gasperini","year":"2014","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0207","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2018.04.018","article-title":"Cell encapsulation: overcoming barriers in cell transplantation in diabetes and beyond","volume":"139","author":"Farina","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0208","first-page":"509","article-title":"The diffusion-chamber technique applied to a study of the nature of homograft resistance","volume":"15","author":"Prehn","year":"1954","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0209","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibtech.2018.01.007","article-title":"Engineering a clinically translatable bioartificial pancreas to treat type I diabetes","volume":"36","author":"Orive","year":"2018","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-017-0901-4","article-title":"Immunological issues after stem cell-based \u03b2 cell replacement","volume":"17","author":"Sordi","year":"2017","journal-title":"Current Diabetes Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0211","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nm0103-104","article-title":"Cell encapsulation: promise and progress","volume":"9","author":"Orive","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0212","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2041731416638198","article-title":"Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet-like insulin-producing aggregates for diabetes treatment","volume":"7","author":"Sabek","year":"2016","journal-title":"Journal of Tissue Engineering"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0213","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700169","article-title":"3D printed vascularized device for subcutaneous transplantation of human islets","volume":"12","author":"Farina","year":"2017","journal-title":"Biotechnol J"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0214","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jbm.820260711","article-title":"Agarose for a bioartificial pancreas","volume":"26","author":"Iwata","year":"1992","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0215","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(94)90067-1","article-title":"Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation","volume":"343","author":"Soon-Shiong","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0216","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.TP.0000053749.36365.7E","article-title":"Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression","volume":"75","author":"Kobayashi","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0217","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1399-3089.2007.00384.x","article-title":"Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation","volume":"14","author":"Elliott","year":"2007","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0218","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/TP.0b013e3181629c25","article-title":"Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression","volume":"85","author":"Wang","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0219","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diacare.29.01.06.dc05-1270","article-title":"Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases","volume":"29","author":"Calafiore","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jdi.12788","article-title":"Microencapsulation for cell therapy of type 1 diabetes mellitus: the interplay between common beliefs, prejudices and real progress","volume":"9","author":"Calafiore","year":"2018","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0221","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd.2017.67","article-title":"Advances in islet encapsulation technologies","volume":"16","author":"Desai","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0222","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13287-017-0646-7","article-title":"Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice","volume":"8","author":"Montanari","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0223","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2013.07.018","article-title":"Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution","volume":"67-68","author":"Scharp","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0224","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183780","article-title":"Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival","volume":"12","author":"Komatsu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0225","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4161\/isl.26304","article-title":"Human islet mass, morphology, and survival after cryopreservation using the Edmonton protocol","volume":"5","author":"Miranda","year":"2013","journal-title":"Islets"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0226","series-title":"Principles of tissue engineering","author":"Robert","year":"2020"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0227","series-title":"Proceedings of SPIE","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1117\/12.304387","article-title":"Implantation of microfabricated immunoisolating biocapsules","author":"Desai","year":"1998"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0228","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.1957.tb52492.x","article-title":"Studies on tissue homotransplantation in mice, using diffusion-chamber methods","volume":"64","author":"Algire","year":"1957","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0229","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/978-1-4419-5786-3_10","article-title":"Inorganic nanoporous membranes for immunoisolated cell-based drug delivery","volume":"670","author":"Mendelsohn","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007890-199807150-00004","article-title":"Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice","volume":"66","author":"Suzuki","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0231","doi-asserted-by":"crossref","DOI":"10.1021\/nn2037863","article-title":"Gated and near-surface diffusion of charged fullerenes in nanochannels","volume":"5","author":"Grattoni","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0232","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1039\/C4NR06209D","article-title":"Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane","volume":"7","author":"Bruno","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0233","unstructured":"Per-Ola Carlsson, U. U. H. An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes Mellitus, < ClinicalTrials.gov, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02064309> (May 17, 2022)."},{"key":"10.1016\/j.jcyt.2023.04.012_bib0234","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/adhm.201400348","article-title":"Delivering enhanced testosterone replacement therapy through nanochannels","volume":"4","author":"Ferrati","year":"2015","journal-title":"Advanced healthcare materials"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0235","article-title":"Survival of encapsulated islets: more than a membrane story","volume":"69","author":"Uriel","year":"2016","journal-title":"World Journal of Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0236","series-title":"ViaCyte Announces First Patients Implanted in Cohort 2 with Potentially Efficacious Dose of PEC-Direct Islet Cell Replacement Therapy","author":"ViaCyte","year":"2018"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0237","unstructured":"Dufrane, D., Gianello, P. R. R. & Melvik, J. E. Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof. Patent. (2012)."},{"key":"10.1016\/j.jcyt.2023.04.012_bib0238","article-title":"A simple and safe clinical procedure for human encapsulated islet transplantation in the subcutaneous tissue for diabetes treatment","volume":"96","author":"Dufrane","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0239","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/db15-1525","article-title":"Bioengineering the endocrine pancreas: Intraomental islet transplantation within a biologic resorbable scaffold","volume":"65","author":"Berman","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0240","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMc1613959","article-title":"Bioengineering of an intraabdominal endocrine pancreas","volume":"376","author":"Baidal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0241","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1002\/adma.201506025","article-title":"Microneedles integrated with pancreatic cells and synthetic glucose-signal amplifiers for smart insulin delivery","volume":"28","author":"Ye","year":"2016","journal-title":"Adv Mater"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0242","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acs.accounts.7b00526","article-title":"Leveraging engineering of cells for drug delivery","volume":"51","author":"Chen","year":"2018","journal-title":"Accounts of chemical research"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0243","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diab.44.3.249","article-title":"Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model","volume":"44","author":"Finegood","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0244","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1210\/endo.138.4.5069","article-title":"Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat","volume":"138","author":"Scaglia","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0245","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1152\/physrev.00025.2004","article-title":"Regulation of pancreatic beta-cell mass","volume":"85","author":"Bouwens","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0246","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1073\/pnas.87.21.8341","article-title":"Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells","volume":"87","author":"Ikehara","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0247","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.18176","volume":"198","author":"Achini-Gutzwiller","year":"2022","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0248","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/diabetes.54.6.1770","article-title":"Prevention of type 1 diabetes with major histocompatibility complex\u2013compatible and nonmarrow ablative hematopoietic stem cell transplants","volume":"54","author":"Beilhack","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0249","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2337\/diabetes.52.1.59","article-title":"Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice","volume":"52","author":"Beilhack","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0250","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nature Reviews Nephrology"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0251","doi-asserted-by":"crossref","first-page":"38308","DOI":"10.1038\/srep38308","article-title":"Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism","volume":"6","author":"Vasandan","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0252","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.3390\/ijms20163876","article-title":"The role of mesenchymal stem cells in radiation-induced lung fibrosis","volume":"20","author":"Zanoni","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0253","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41418-017-0006-2","article-title":"Kynurenic acid, an IDO metabolite, controls TSG-6-mediatedimmunosuppression of human mesenchymal stem cells","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0254","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1314709","article-title":"Proangiogenic features of mesenchymal stem cells and their therapeutic applications","volume":"2016","author":"Tao","year":"2016","journal-title":"Stem Cells International"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0255","article-title":"Engineering islets from stem cells: the optimal solution for the treatment of diabetes?","volume":"13","author":"Du","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0256","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2230-973X.108958","article-title":"Novel gene delivery systems","volume":"3","author":"Manjila","year":"2013","journal-title":"International Journal of Pharmaceutical Investigation"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0257","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00268-007-9168-2","article-title":"Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene","volume":"31","author":"Xu","year":"2007","journal-title":"World Journal of Surgery"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0258","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1089\/scd.2009.0010","article-title":"Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1","volume":"18","author":"Lin","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0259","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/scd.2016.0275","article-title":"Efficacy of autologous bone marrow-derived mesenchymal stem cell and mononuclear cell transplantation in type 2 diabetes mellitus: a randomized, placebo-controlled comparative study","volume":"26","author":"Bhansali","year":"2016","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.jcyt.2023.04.012_bib0260","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:49:51Z","timestamp":1761443391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":260,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1465324923001299"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.04.012","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cells therapy for diabetes: from past to future","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}